Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2022 | What is the latest progress in gene research in MS?

Lars Alfredsson • 25 Feb 2022
ACTRIMS 2022
Multiple Sclerosis and Related Disorders

Lars Alfredsson, PhD, Karolinska Institutet, Stockholm, Sweden, discusses the latest genetic research into multiple sclerosis (MS), whereby over 200 genetic polymorphisms have been associated with risk of MS and more continue to be identified. This interview took place at the ACTRIMS Forum 2022 in West Palm Beach, Florida.

More from Lars Alfredsson

1:56
Epstein-Barr virus as a predominant trigger of multiple sclerosis
Lars Alfredsson • 25 Feb 2022
4:10
Environmental interactions in multiple sclerosis according to DRB1 hetero-homozygosity
Lars Alfredsson • 25 Feb 2022
3:32
Factors affecting the risk of relapsing- and progressive-onset multiple sclerosis
Lars Alfredsson • 25 Feb 2022

Related Videos

5:02
Differential immune cell modulation with highly vs moderately efficacious DMTs in MS
Shane Arsenault • 14 Apr 2024
1:59
Exciting remyelination research in MS: cell therapy and neuromodulation
Giancarlo Comi • 23 Mar 2024
2:30
The potential of wearables for continuous activity monitoring in MS
Giancarlo Comi • 23 Mar 2024
3:19
Is MS progressive from onset? Challenging the classical understanding of progression
Giancarlo Comi • 23 Mar 2024
The content of VJNeurology is intended for healthcare professionals